What is a health benefit? An evaluation of EFSA opinions on health benefits with reference to probiotics
äºBeneficial MicrobesSearch for other papers by K.H. Binnendijk in
Current site
Google Scholar
Search for other papers by G.T. Rijkers in
Current site
Google Scholar
Probiotics are microorganisms that have a beneficial effect on the health of the host. However, before these effects can be referred to as beneficial to human health, such claims need to be evaluated by regulatory institutes such as the European Food Safety Authority (EFSA). The EFSA Panel on Dietetic Products, Nutrition and allergies (NDA) has published their opinions regarding health claims including probiotics, most of which were rejected in the past years. Using the EFSA database, the NDA dossiers published between 2005 and 2013 were analysed to provide an overview on what grounds certain health effects were accepted as beneficial and others not. The NDA Panel distinguishes between claims that are definitely beneficial, possibly beneficial or non-beneficial to human health. Overall, 78% of all analysed health claims are considered by the NDA Panel as (possibly) beneficial to human health, in particular the gut health effects. Since, in many cases, the scientific substantiation of a particular health claim was deemed insufficient, most applications were turned down. For future health claim applications concerning probiotics to be successful, they should include specific statements on what exactly the microorganism affects, and the scientific substantiation of the particular health claim should be based on the targeted (general) population.
Purchase
Buy instant access (PDF download and unlimited online access):
Institutional Login
Log in with Open Athens, Shibboleth, or your institutional credentials
Personal login
Log in with your brill.com account
-
European Commission (EC), 2007. Corrigendum to Regulation (EC) No 1924/2006 of the European Parliament and of the Council of 20 December 2006 on nutrition and health claims made on foods. Official Journal of the European Union L12: 3-18.
-
European Commission (EC), 2010. Regulation (EU) No. 116/2010 of 9 February 2010 amending Regulation (EC) No. 1924/2006 of the European Parliament and of the Council with regard to the list of nutrition claims. Official Journal of the European Union L37: 16-18.
-
European Commission (EC), 2013. EU Register on nutrition and health claims made on foods. Available at: http://www.ec.europa.eu/nuhclaims. http://www.ec.europa.eu/nuhclaims
-
European Food Safety Authority (EFSA), undated. Independent scientific advice on food and feed safety. Available at: http://www.efsa.europa.eu/en/aboutefsa.htm. http://www.efsa.europa.eu/en/aboutefsa.htm
-
European Food Safety Authority Panel on Dietetic Products, Nutrition and Allergies (NDA), 2008a. Scientific Opinion of the Panel on Dietetic Products Nutrition and Allergies on a request from Unilever PLC/NV on plant sterols and lower/reduced blood cholesterol, reduced the risk of (coronary) heart disease. The EFSA Journal 6: 781 (12 pp.).
-
European Food Safety Authority Panel on Dietetic Products, Nutrition and Allergies (NDA), 2008b. Scientific Opinion of the Panel on Dietetic Products, Nutrition and Allergies on a request from McNeil Nutritionals Ltd. related to the scientific substantiation of a health claim on plant stanol esters and lower/reduced blood cholesterol and reduced risk of (coronary) heart disease. The EFSA Journal 6: 825 (13 pp.).
-
European Food Safety Authority Panel on Dietetic Products, Nutrition and Allergies (NDA), 2009a. Scientific Opinion of the Panel on Dietetic Products, Nutrition and Allergies on a request from Provexis Natural Products Limited on water-soluble tomato concentrate (WSTC I and II) and platelet aggregation. The EFSA Journal 7: 1101 (15 pp.).
-
European Food Safety Authority Panel on Dietetic Products, Nutrition and Allergies (NDA), 2009b. Scientific Opinion of the Panel on Dietetic Products, Nutrition and Allergies on a request from Danone France related to the scientific substantiation of a health claim on phytosterols and lowering/reducing blood cholesterol and reduced risk of (coronary) heart disease. The EFSA Journal 7: 1177 (12 pp.).
-
European Food Safety Authority Panel on Dietetic Products, Nutrition and Allergies (NDA), 2010. Scientific Opinion on the substantiation of a health claim related to oat beta-glucan and lowering blood cholesterol and reduced risk of (coronary) heart disease pursuant to Article 14 of Regulation (EC) No 1924/2006. EFSA Journal 8: 1885 (15 pp.).
-
European Food Safety Authority Panel on Dietetic Products, Nutrition and Allergies (NDA), 2011a. Scientific Opinion on the substantiation of health claims related to water and maintenance of normal physical and cognitive function (ID 1102, 1209, 1294, 1331), maintenance of normal thermoregulation (ID 1208) and âbasic requirement of all living thingsâ (ID 1207) pursuant to Article 13(1) of Regulation (EC) No 1924/2006. EFSA Journal 9: 2075 (16 pp.).
-
European Food Safety Authority Panel on Dietetic Products, Nutrition and Allergies (NDA), 2011b. Scientific Opinion on the substantiation of health claims related to Lactobacillus rhamnosus GR-1 (ATCC 55826) in combination with Lactobacillus reuteri RC-14 (ATCC 55845) and defence against vaginal pathogens by increasing the proportion of lactobacilli and/or decreasing the proportion of potentially pathogenic bacteria and/or yeasts (ID 945) pursuant to Article 13(1) of Regulation (EC) No 1924/2006. EFSA Journal 9: 2232 (15 pp.).
-
European Food Safety Authority Panel on Dietetic Products, Nutrition and Allergies (NDA), 2011c. Guidance on the scientific requirements for health claims related to gut and immune function. EFSA Journal 9: 1984 (12 pp.).
-
European Food Safety Authority Panel on Dietetic Products, Nutrition and Allergies (NDA), 2012a. Scientific Opinion on the substantiation of health claims related to the substantiation of health claims related to various and reduction of gastrointestinal discomfort (ID 1030, 2956, 2958, 2961, 2963, 2966, 2970), decreasing potentially pathogenic gastro-intestinal microorganisms (ID 1030, 2956, 2958, 2961, 2963, 2966, 2970), improved lactose digestion (ID 1030, 2956, 2958, 2961, 2963, 2966, 2970), âintestinal flora/digestive healthâ (ID 4231), defence against vaginal pathogens (ID 2950, 2957, 2967) and increasing IL-10 production and/or enhancing the activity of natural killer cells (ID 2960, 2962, 2971) (further assessment) pursuant to Article 13(1) of Regulation (EC) No 1924/2006. EFSA Journal 10: 2858 (34 pp.).
-
European Food Safety Authority Panel on Dietetic Products, Nutrition and Allergies (NDA), 2012b. Scientific Opinion on the substantiation of health claims related to Lactobacillus casei DG CNCM I-1572 and decreasing potentially pathogenic gastro-intestinal microorganisms (ID 2949, 3061, further assessment) pursuant to Article 13(1) of Regulation (EC) No 1924/2006. EFSA Journal 10: 2723 (15 pp.).
-
Food and Agriculture Organization of the United Nations and World Health Organization (FAO/WHO), 2001. Health and nutritional properties of probiotics in food, including powder milk with live lactic acid bacteria. Report of a Joint FAO/WHO expert consultation on evaluation of health and nutritional properties of probiotics in food, including powder milk with live lactic acid bacteria. Available at: ftp://ftp.fao.org/docrep/fao/meeting/009/y6398e.pdf. ftp://ftp.fao.org/docrep/fao/meeting/009/y6398e.pdf
-
Ison, C.A. and Hay, P.E., 2002. Validation of a simplified grading of Gram stained vaginal smears for use in genitourinary medicine clinics. Sexually Transmitted Infections 78: 413-415.
'Validation of a simplified grading of Gram stained vaginal smears for use in genitourinary medicine clinics ' () 78 Sexually Transmitted Infections : 413 -415.
-
Salminen, S. and Van Loveren, H., 2012. Probiotics and prebiotics: health claim substantiation. Microbial Ecology in Health and Disease 23: 18568.
'Probiotics and prebiotics: health claim substantiation ' () 23 Microbial Ecology in Health and Disease : 18568.
-
Salminen, S., Ouwehand, A., Benno, Y. and Lee, Y.K., 1999. Probiotics: how should they be defined? Trends in Food Science and Technology 10: 107-110.
'Probiotics: how should they be defined? ' () 10 Trends in Food Science and Technology : 107 -110.
-
Sanders, M.E., 2008. Probiotics: definition, sources, selection, and uses. Clinical Infectious Diseases 46 Suppl. 2: S58-S61.
'Probiotics: definition, sources, selection, and uses ' () 46 Clinical Infectious Diseases : S58 -S61.
-
Schrezenmeir, J. and De Vrese, M., 2001. Probiotics, prebiotics, and synbiotics - approaching a definition. American Journal of Clinical Nutrition 78: 361s-364s.
'Probiotics, prebiotics, and synbiotics - approaching a definition ' () 78 American Journal of Clinical Nutrition : 361s -364s.
-
Starling, S., 2012. It's official! There are 222 general function approved health claims in the EU; 1500+ rejected. Available at: http://www.nutraingredients.com/On-your-radar/Health-claims/It-s-official!-There-are-222-general-function-approved-health-claims-in-the-EU-1500-rejected. http://www.nutraingredients.com/On-your-radar/Health-claims/It-s-official!-There-are-222-general-function-approved-health-claims-in-the-EU-1500-rejected
-
World Health Organization (WHO), 1946. Preamble of the World Health Organization as adopted by the International Health Conference, New York, 19-22 June, 1946. Available at: http://www.who.int/about/definition/en/print.html. http://www.who.int/about/definition/en/print.html
Supplementary Materials
| å ¨é¨æé´ | è¿å»ä¸å¹´ | è¿å»30天 | |
|---|---|---|---|
| æè¦æµè§æ¬¡æ° | 474 | 156 | 14 |
| å ¨ææµè§æ¬¡æ° | 155 | 76 | 0 |
| PDFä¸è½½æ¬¡æ° | 25 | 0 | 0 |
What is a health benefit? An evaluation of EFSA opinions on health benefits with reference to probiotics
äºBeneficial MicrobesSearch for other papers by K.H. Binnendijk in
Current site
Google Scholar
PubMed
Search for other papers by G.T. Rijkers in
Current site
Google Scholar
PubMed
Probiotics are microorganisms that have a beneficial effect on the health of the host. However, before these effects can be referred to as beneficial to human health, such claims need to be evaluated by regulatory institutes such as the European Food Safety Authority (EFSA). The EFSA Panel on Dietetic Products, Nutrition and allergies (NDA) has published their opinions regarding health claims including probiotics, most of which were rejected in the past years. Using the EFSA database, the NDA dossiers published between 2005 and 2013 were analysed to provide an overview on what grounds certain health effects were accepted as beneficial and others not. The NDA Panel distinguishes between claims that are definitely beneficial, possibly beneficial or non-beneficial to human health. Overall, 78% of all analysed health claims are considered by the NDA Panel as (possibly) beneficial to human health, in particular the gut health effects. Since, in many cases, the scientific substantiation of a particular health claim was deemed insufficient, most applications were turned down. For future health claim applications concerning probiotics to be successful, they should include specific statements on what exactly the microorganism affects, and the scientific substantiation of the particular health claim should be based on the targeted (general) population.
| å ¨é¨æé´ | è¿å»ä¸å¹´ | è¿å»30天 | |
|---|---|---|---|
| æè¦æµè§æ¬¡æ° | 474 | 156 | 14 |
| å ¨ææµè§æ¬¡æ° | 155 | 76 | 0 |
| PDFä¸è½½æ¬¡æ° | 25 | 0 | 0 |
